COSCIENS Biopharma, Inc. (CSCI.TO)
7.50
+0.26
(+3.59%)
CAD |
TSX |
Aug 25, 16:00
COSCIENS Biopharma Shareholders Equity (Quarterly) : 21.06M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.06M |
| March 31, 2026 | 21.38M |
| December 31, 2025 | 5.266M |
| September 30, 2025 | 7.068M |
| June 30, 2025 | 9.684M |
| March 31, 2025 | 14.60M |
| December 31, 2024 | 18.93M |
| September 30, 2024 | 27.04M |
| June 30, 2024 | 35.89M |
| March 31, 2024 | 17.55M |
| December 31, 2023 | 27.74M |
| September 30, 2023 | 35.53M |
| June 30, 2023 | 38.48M |
| March 31, 2023 | 42.24M |
| December 31, 2022 | 48.47M |
| September 30, 2022 | 67.90M |
| June 30, 2022 | 70.04M |
| March 31, 2022 | 66.40M |
| December 31, 2021 | 66.93M |
| September 30, 2021 | 75.92M |
| June 30, 2021 | 75.97M |
| March 31, 2021 | 80.66M |
| December 31, 2020 | 16.83M |
| September 30, 2020 | 20.23M |
| June 30, 2020 | 1.268M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.401M |
| December 31, 2019 | -3.194M |
| September 30, 2019 | -2.904M |
| June 30, 2019 | -3.957M |
| March 31, 2019 | -4.756M |
| December 31, 2018 | 2.605M |
| September 30, 2018 | 9.578M |
| June 30, 2018 | 12.51M |
| March 31, 2018 | 14.88M |
| December 31, 2017 | -3.487M |
| September 30, 2017 | -2.445M |
| June 30, 2017 | 5.832M |
| March 31, 2017 | 7.138M |
| December 31, 2016 | 8.331M |
| September 30, 2016 | 4.313M |
| June 30, 2016 | 11.75M |
| March 31, 2016 | 21.08M |
| December 31, 2015 | 30.03M |
| September 30, 2015 | 17.19M |
| June 30, 2015 | 11.74M |
| March 31, 2015 | 25.81M |
| December 31, 2014 | 16.78M |
| September 30, 2014 | 8.274M |
| June 30, 2014 | 10.92M |
| March 31, 2014 | 18.13M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Spectral Medical, Inc. | -70.07M |
| Resverlogix Corp. | -133.75M |
| Theratechnologies, Inc. | -38.39M |
| Restart Life Sciences Corp. | 1.543M |
| Defence Therapeutics Inc | 5.415M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.74M |
| Total Liabilities (Quarterly) | 5.688M |
| Debt to Equity Ratio | 0.1318 |
| Current Ratio | 4.328 |
| Net Debt Paydown Yield | 0.83% |